Iovance Biotherapeutics
IOVA
IOVA
248 hedge funds and large institutions have $379M invested in Iovance Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 92 increasing their positions, 72 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
248
Holders Change
-52
Holders Change %
-17.33%
% of All Funds
3.33%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
37
Increased
92
Reduced
72
Closed
82
Calls
$3.58M
Puts
$2.55M
Net Calls
+$1.03M
Net Calls Change
-$284K
Top Buyers
| 1 |
Millennium Management
New York
|
+$15.8M |
| 2 |
MFM
MHR Fund Management
New York
|
+$7.83M |
| 3 |
Two Sigma Investments
New York
|
+$7.29M |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$4.82M |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$4.42M |
